The promise and perils of biomarker testing in gynecologic cancers.
Publication
, Journal Article
Fitch, KC; Previs, RA; Moss, HA
Published in: Gynecologic oncology
October 2025
Duke Scholars
Published In
Gynecologic oncology
DOI
EISSN
1095-6859
ISSN
0090-8258
Publication Date
October 2025
Volume
201
Start / End Page
53 / 55
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Fitch, K. C., Previs, R. A., & Moss, H. A. (2025). The promise and perils of biomarker testing in gynecologic cancers. Gynecologic Oncology, 201, 53–55. https://doi.org/10.1016/j.ygyno.2025.07.019
Fitch, Katherine C., Rebecca A. Previs, and Haley A. Moss. “The promise and perils of biomarker testing in gynecologic cancers.” Gynecologic Oncology 201 (October 2025): 53–55. https://doi.org/10.1016/j.ygyno.2025.07.019.
Fitch KC, Previs RA, Moss HA. The promise and perils of biomarker testing in gynecologic cancers. Gynecologic oncology. 2025 Oct;201:53–5.
Fitch, Katherine C., et al. “The promise and perils of biomarker testing in gynecologic cancers.” Gynecologic Oncology, vol. 201, Oct. 2025, pp. 53–55. Epmc, doi:10.1016/j.ygyno.2025.07.019.
Fitch KC, Previs RA, Moss HA. The promise and perils of biomarker testing in gynecologic cancers. Gynecologic oncology. 2025 Oct;201:53–55.
Published In
Gynecologic oncology
DOI
EISSN
1095-6859
ISSN
0090-8258
Publication Date
October 2025
Volume
201
Start / End Page
53 / 55
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis